Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …

BACKGROUND Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
differ in the severity of disease. We hypothesized that characteristics of SARS-…

The ongoing coronavirus disease 2019 (COVID-19) pandemic is a substantial challenge for
health-care systems and their infrastructure. RT-PCR-based diagnostic confirmation of …

Comparative analyses of the immunogenicity and reactogenicity of homologous and
heterologous SARS-CoV-2 vaccine-regimens will inform optimized vaccine strategies. Here we …

Patients with metastasized carcinoma of the pancreas have a very poor prognosis, and long-term
survival cannot be expected. This case report describes two patients with an initial …

Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were …

Context: Low-grade inflammation is associated with insulin resistance and precedes the onset
of type 2 diabetes mellitus in adults, but there are no comparable data in youth. Objective: …

Background Individual doses of dual-dose vaccine-regimens are sequentially administered
into the deltoid muscle, but little attention has so far been paid to the immunological effects of …

Heterologous priming with the ChAdOx1-nCoV-19 vector-vaccine followed by boosting with
an mRNA-vaccine is currently recommended in Germany, although data on immunogenicity …

Dengue virus (DENV) antibody assays frequently cross-react with sera from individuals who
have been infected with or vaccinated against related flaviviruses. The goal of this study …